A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder

Neal R. Cutler, Jan M. Keppel Hesselink, John J. Sramek
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry, May 1994, Elsevier
  • DOI: 10.1016/0278-5846(94)90003-5

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/0278-5846(94)90003-5

The following have contributed to this page: jan keppel hesselink